Ken Nelson is the Board Chairman and an investor at CardiaCare, where they oversee development on a wearable therapy for atrial fibrillation. They are also a partner at MedTech Advantage Fund, focusing on investing in MedTech Innovator alumni companies, and serve on the boards of multiple digital health and MedTech startups, including Acarix and HeartBeam. Ken's previous roles include Chief Commercial Officer at Bardy Diagnostics and Head of Digital Health at BIOTRONIK. They hold a Bachelor of Arts in Economics, Business Administration, and Spanish from Vanderbilt University.
Location
Dallas, United States